Long-term Oncological Outcomes from an Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)
- PMID: 31740072
- DOI: 10.1016/j.eururo.2019.10.027
Long-term Oncological Outcomes from an Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)
Abstract
Background: The long-term oncological outcomes of laparoscopic (LRC) and robotic-assisted radical cystectomy (RARC) are still maturing compared with open radical cystectomy (ORC).
Objective: To evaluate the 5-yr oncological outcomes of patients recruited into the randomised trial of Open, Laparoscopic and Robot Assisted Cystectomy (CORAL) and extracorporeal urinary diversion.
Design, setting, and participants: A review of prospectively maintained database of 60 patients with muscle-invasive bladder cancer (MIBC) or high-risk nonmuscle-invasive bladder cancer (HRNMIBC) who were previously randomised in the CORAL trial to receive ORC, RARC, or LRC. This trial was designed to compare the perioperative and early oncological outcomes of these techniques.
Outcome measurements and statistical analysis: The outcomes of interest included 5-yr recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS). Kaplan-Meier curves were used to plot the recurrence and survival data. The curves between RFS, CSS, and OS were compared using the log-rank test. A two-sided p value <0.05 was considered significant. Results were analysed on the basis of intention to treat.
Results and limitations: A total of 60 patients with either MIBC (n=38) or HRNMIBC (n=21) were randomised in the CORAL trial to receive ORC, RARC, or LRC. The 5-yr RFS was 60%, 58%, and 71%; 5-yr CSS was 64%, 68%, and 69%; and 5-yr OS was 55%, 65%, and 61% for ORC, RARC, and LRC, respectively. There was no significant difference in RFS, CSS, and OS between the three surgical arms. The principal limitation is the small sample size.
Conclusions: There was no difference in 5-yr RFS, CSS, and OS rates of patients who underwent ORC, RARC, and LRC for management of bladder cancer. Minimally invasive techniques achieved equivalent oncological outcomes to the gold standard of ORC. However, the study was based at a single institution with a small sample size.
Patient summary: Patients who agreed to participate in the randomised trial of either open, laparoscopic, or robotic-assisted radical cystectomy for bladder cancer did not have different cancer outcomes at 5yr.
Keywords: Bladder cancer; Open cystectomy; Robotic cystectomy.
Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Re: Long-Term Oncological Outcomes from an Early Phase Randomised Controlled Three-Arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL).J Urol. 2020 Sep;204(3):598. doi: 10.1097/JU.0000000000001166. Epub 2020 Jun 18. J Urol. 2020. PMID: 32552207 No abstract available.
-
Minimally invasive versus open radical cystectomy: long term oncologic outcomes compared.Transl Androl Urol. 2020 Jun;9(3):1006-1008. doi: 10.21037/tau-2020-03. Transl Androl Urol. 2020. PMID: 32676384 Free PMC article. No abstract available.
-
Radical cystectomy-what is the optimal surgical approach?Transl Androl Urol. 2020 Oct;9(5):2308-2312. doi: 10.21037/tau-20-880. Transl Androl Urol. 2020. PMID: 33209702 Free PMC article. No abstract available.
-
Growing evidence for benefits of minimally invasive radical cystectomy.Transl Androl Urol. 2020 Dec;9(6):2459-2461. doi: 10.21037/tau-20-873. Transl Androl Urol. 2020. PMID: 33457215 Free PMC article. No abstract available.
-
Open versus minimal invasive radical cystectomy.Transl Androl Urol. 2020 Dec;9(6):2471-2473. doi: 10.21037/tau-20-878. Transl Androl Urol. 2020. PMID: 33457218 Free PMC article. No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
